Literature DB >> 23542310

Identification and characterization of a transient outward K+ current in human induced pluripotent stem cell-derived cardiomyocytes.

Jonathan M Cordeiro1, Vladislav V Nesterenko, Serge Sicouri, Robert J Goodrow, Jacqueline A Treat, Mayurika Desai, Yuesheng Wu, Michael Xavier Doss, Charles Antzelevitch, José M Di Diego.   

Abstract

BACKGROUND: The ability to recapitulate mature adult phenotypes is critical to the development of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) as models of disease. The present study examines the characteristics of the transient outward current (Ito) and its contribution to the hiPSC-CM action potential (AP).
METHOD: Embryoid bodies were made from a hiPS cell line reprogrammed with Oct4, Nanog, Lin28 and Sox2. Sharp microelectrodes were used to record APs from beating-clusters (BC) and patch-clamp techniques were used to record Ito in single hiPSC-CM. mRNA levels of Kv1.4, KChIP2 and Kv4.3 were quantified from BCs.
RESULTS: BCs exhibited spontaneous beating (60.5±2.6 bpm) and maximum-diastolic-potential (MDP) of 67.8±0.8 mV (n=155). A small 4-aminopyridine-sensitive phase-1-repolarization was observed in only 6/155 BCs. A robust Ito was recorded in the majority of cells (13.7±1.9 pA/pF at +40 mV; n=14). Recovery of Ito from inactivation (at -80 mV) showed slow kinetics (τ1=200±110 ms (12%) and τ2=2380±240 ms (80%)) accounting for its minimal contribution to the AP. Transcript data revealed relatively high expression of Kv1.4 and low expression of KChIP2 compared to human native ventricular tissues. Mathematical modeling predicted that restoration of IK1 to normal levels would result in a more negative MDP and a prominent phase-1-repolarization.
CONCLUSION: The slow recovery kinetics of Ito coupled with a depolarized MDP account for the lack of an AP notch in the majority of hiPSC-CM. These characteristics reveal a deficiency for the development of in vitro models of inherited cardiac arrhythmia syndromes in which Ito-induced AP notch is central to the disease phenotype.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23542310      PMCID: PMC3779808          DOI: 10.1016/j.yjmcc.2013.03.014

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  38 in total

1.  Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males.

Authors:  José M Di Diego; Jonathan M Cordeiro; Robert J Goodrow; Jeffrey M Fish; Andrew C Zygmunt; Guillermo J Pérez; Fabiana S Scornik; Charles Antzelevitch
Journal:  Circulation       Date:  2002-10-08       Impact factor: 29.690

2.  Properties of potassium currents in Purkinje cells of failing human hearts.

Authors:  Wei Han; Liming Zhang; Gernot Schram; Stanley Nattel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-08-15       Impact factor: 4.733

3.  Age-related appearance of outward currents may contribute to developmental differences in ventricular repolarization.

Authors:  C D Jeck; P A Boyden
Journal:  Circ Res       Date:  1992-12       Impact factor: 17.367

4.  Gene expression signatures defining fundamental biological processes in pluripotent, early, and late differentiated embryonic stem cells.

Authors:  John Antonydas Gaspar; Michael Xavier Doss; Johannes Winkler; Vilas Wagh; Jürgen Hescheler; Raivo Kolde; Jaak Vilo; Herbert Schulz; Agapios Sachinidis
Journal:  Stem Cells Dev       Date:  2012-04-17       Impact factor: 3.272

5.  Role of an inwardly rectifying potassium current in rabbit ventricular action potential.

Authors:  Y Shimoni; R B Clark; W R Giles
Journal:  J Physiol       Date:  1992-03       Impact factor: 5.182

6.  Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent.

Authors:  R Dumaine; J A Towbin; P Brugada; M Vatta; D V Nesterenko; V V Nesterenko; J Brugada; R Brugada; C Antzelevitch
Journal:  Circ Res       Date:  1999-10-29       Impact factor: 17.367

7.  A dynamic model of the cardiac ventricular action potential. I. Simulations of ionic currents and concentration changes.

Authors:  C H Luo; Y Rudy
Journal:  Circ Res       Date:  1994-06       Impact factor: 17.367

8.  Transient outward current in human ventricular myocytes of subepicardial and subendocardial origin.

Authors:  E Wettwer; G J Amos; H Posival; U Ravens
Journal:  Circ Res       Date:  1994-09       Impact factor: 17.367

9.  Two components of the delayed rectifier K+ current in ventricular myocytes of the guinea pig type. Theoretical formulation and their role in repolarization.

Authors:  J Zeng; K R Laurita; D S Rosenbaum; Y Rudy
Journal:  Circ Res       Date:  1995-07       Impact factor: 17.367

10.  Phenotypic differences in transient outward K+ current of human and canine ventricular myocytes: insights into molecular composition of ventricular Ito.

Authors:  Fadi G Akar; Richard C Wu; Isabelle Deschenes; Antonis A Armoundas; Valentino Piacentino; Steven R Houser; Gordon F Tomaselli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-10-02       Impact factor: 4.733

View more
  27 in total

Review 1.  Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine.

Authors:  Elaheh Karbassi; Aidan Fenix; Silvia Marchiano; Naoto Muraoka; Kenta Nakamura; Xiulan Yang; Charles E Murry
Journal:  Nat Rev Cardiol       Date:  2020-02-03       Impact factor: 32.419

Review 2.  Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine.

Authors:  Nazish Sayed; Chun Liu; Joseph C Wu
Journal:  J Am Coll Cardiol       Date:  2016-05-10       Impact factor: 24.094

3.  Novel Therapeutic Strategies for the Management of Ventricular Arrhythmias Associated with the Brugada Syndrome.

Authors:  Bence Patocskai; Charles Antzelevitch
Journal:  Expert Opin Orphan Drugs       Date:  2015-05-13       Impact factor: 0.694

Review 4.  Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as Models for Cardiac Channelopathies: A Primer for Non-Electrophysiologists.

Authors:  Priyanka Garg; Vivek Garg; Rajani Shrestha; Michael C Sanguinetti; Timothy J Kamp; Joseph C Wu
Journal:  Circ Res       Date:  2018-07-06       Impact factor: 17.367

Review 5.  Human-Induced Pluripotent Stem Cell-Based Modeling of Cardiac Storage Disorders.

Authors:  Bradley C Nelson; Sherin I Hashem; Eric D Adler
Journal:  Curr Cardiol Rep       Date:  2017-03       Impact factor: 2.931

Review 6.  Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair.

Authors:  Matthew E Hartman; Dao-Fu Dai; Michael A Laflamme
Journal:  Adv Drug Deliv Rev       Date:  2015-05-14       Impact factor: 15.470

7.  Genetic Algorithm For Fitting Cardiac Cell Biophysical Model Formulations.

Authors:  Akwasi Darkwah Akwaboah; Pascal Yamlome; Jacqueline A Treat; Jonathan M Cordeiro; Makarand Deo
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2020-07

8.  Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Dongrui Ma; Heming Wei; Jun Lu; Dou Huang; Zhenfeng Liu; Li Jun Loh; Omedul Islam; Reginald Liew; Winston Shim; Stuart A Cook
Journal:  Stem Cell Res Ther       Date:  2015-03-19       Impact factor: 6.832

9.  An in silico hiPSC-Derived Cardiomyocyte Model Built With Genetic Algorithm.

Authors:  Akwasi D Akwaboah; Bright Tsevi; Pascal Yamlome; Jacqueline A Treat; Maila Brucal-Hallare; Jonathan M Cordeiro; Makarand Deo
Journal:  Front Physiol       Date:  2021-06-16       Impact factor: 4.566

10.  Overlap Arrhythmia Syndromes Resulting from Multiple Genetic Variations Studied in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Jacqueline A Treat; Ryan Pfeiffer; Hector Barajas-Martinez; Robert J Goodrow; Corina Bot; Rodolfo J Haedo; Ronald Knox; Jonathan M Cordeiro
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.